TRYPTOPHAN-DERIVED NK1 ANTAGONISTS - CONFORMATIONALLY CONSTRAINED HETEROCYCLIC BIOISOSTERES OF THE ESTER LINKAGE

被引:65
作者
LEWIS, RT
MACLEOD, AM
MERCHANT, KJ
KELLEHER, F
SANDERSON, I
HERBERT, RH
CASCIERI, MA
SADOWSKI, S
BALL, RG
HOOGSTEEN, K
机构
[1] Merck Sharp & Dohme Research Laboratories, Neuroscience Research Center, Harlow, Essex CM20 2QR, Terlings Park, Eastwick Road
[2] Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, NJ
[3] Department of Biophysical Chemistry, Merck Research Laboratories, Rahway, NJ
关键词
D O I
10.1021/jm00006a011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The 3,5-bis(trifluoromethyl)benzyl ester of N-acetyl-L-tryptophan 1 (L-732,138) has been identified previously as a potent and selective substance P receptor antagonist. A series of analogs which introduced a 6-membered heterocyclic ring into the backbone of this structure were prepared for evaluation as bioisosteric replacements of the ester linkage of 1. The 2,5-dioxopiperazine 2 had very weak receptor affinity, but 2-oxopiperazine 5 exhibited modest activity. Examination of the conformations accessible to the substituents on these templates led to exploration of the corresponding 5-membered heterocyclic rings. This study culminated in the identification of oxazolidinedione 14 as a suitable ester mimic in terms of the retention of good NK1 binding affinity.
引用
收藏
页码:923 / 933
页数:11
相关论文
共 40 条
  • [1] FORMAL TOTAL SYNTHESIS OF (-)-INDOLMYCIN
    AKITA, H
    KAWAGUCHI, T
    ENOKI, Y
    OISHI, T
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (02) : 323 - 328
  • [2] BARNES P, 1993, TRENDS PHARMACOL SCI, V11, P185
  • [3] ANTIEMETIC PROFILE OF A NONPEPTIDE NEUROKININ-NK(1) RECEPTOR ANTAGONIST, CP-99,994, IN FERRETS
    BOUNTRA, C
    BUNCE, K
    DALE, T
    GARDNER, C
    JORDAN, C
    TWISSELL, D
    WARD, P
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (01) : R3 - R4
  • [4] BRANA MF, 1992, LIEBIGS ANN CHEM, P867
  • [5] CASCIERI MA, 1994, J BIOL CHEM, V269, P6587
  • [6] CASCIERI MA, 1992, MOL PHARMACOL, V42, P458
  • [7] DELGIUDICE MR, 1990, J HETEROCYCLIC CHEM, V27, P967
  • [8] DISCOVERY OF A POTENT SUBSTANCE-P ANTAGONIST - RECOGNITION OF THE KEY MOLECULAR DETERMINANT
    DESAI, MC
    LEFKOWITZ, SL
    THADEIO, PF
    LONGO, KP
    SNIDER, RM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (26) : 4911 - 4913
  • [9] QUANTITATIVE-EVALUATION OF STERIC EFFECTS IN SN2 RING-CLOSURE REACTIONS
    DETAR, DF
    LUTHRA, NP
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1980, 102 (13) : 4505 - 4512
  • [10] SPANTIDE-II, AN EFFECTIVE TACHYKININ ANTAGONIST HAVING HIGH POTENCY AND NEGLIGIBLE NEUROTOXICITY
    FOLKERS, K
    FENG, DM
    ASANO, N
    HAKANSON, R
    WEISENFELDHALLIN, Z
    LEANDER, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4833 - 4835